UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) April 14, 2011
SyntheMed, Inc.
(Exact name of Registrant as Specified in its Charter)
| Delaware | 0-20580 | 14-1745197 |
| (State or Other Jurisdiction | (Commission file Number) | (IRS Employer |
| of Incorporation) | Identification No.) | |
| 200 Middlesex Essex Turnpike, Suite 210, Iselin, New Jersey | 08830 | |
| (Address of principal executive offices) | (Zip Code) | |
Registrant's telephone number, including area code: 732-404-1117
________________________________________________________
(Former name or address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Section 1 – Registrant’s Business and Operations
Item 1.01 Entry into a Material Definitive Agreement
Effective April 14, 2011, we amended the previously announced agreement and plan of merger with Pathfinder, LLC to extend from April 30, 2011 to May 31, 2011 the outside date by which the merger must occur, after which a non-breaching party shall have the right to terminate the agreement for any reason or no reason. The amendment also corrects certain tax code references. At the same time, we also amended the revolving credit and security agreement with Pathfinder to extend to May 31, 2011 the period of time during which we are entitled to request drawdowns under that agreement.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| SyntheMed, Inc. | |||
|
Date: April 21, 2011
|
By:
|
s/Richard L. Franklin | |
| Richard L. Franklin, M.D., Ph.D. | |||
|
Executive Chairman
|
|||
3